CLINICAL_TRIALS
trial_result
· 2014-06-09
Clinical Trial Update: Ketamine Infusion for Obsessive-Compulsive Disorder [Phase 2]
Summary
A Phase 2 clinical trial evaluating ketamine infusion for obsessive-compulsive disorder has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Obsessive-compulsive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-06-09